Chairperson

Manulife announces additions to its Board of Directors

Retrieved on: 
Tuesday, March 5, 2024

He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University.

Key Points: 
  • He holds a Bachelor of Commerce from Saint Mary's University and a Ph.D. in Management from Queen's University.
  • Mr. Kanak is a former senior executive with deep insurance experience in Asia.
  • He served in senior executive positions at American International Group (AIG) for over 14 years before joining Prudential.
  • "Mike, Don, Anna and John bring skills and experience critical to supporting the Board of Directors' effective oversight of Manulife given its growth ambitions and strategic priorities," said Don Lindsay, Chair of the Board, Manulife.

Agora Data Announces Sharon Mancero as Managing Director to Drive Innovation and Growth in Auto Finance Solutions for Lenders

Retrieved on: 
Tuesday, March 5, 2024

ARLINGTON, Texas, March 5, 2024 /PRNewswire/ -- Agora Data, a fintech company that provides technology, capital, and guidance with predictable loan performance and analytics for the subprime automotive industry, announces the appointment of Sharon Mancero as Managing Director.

Key Points: 
  • ARLINGTON, Texas, March 5, 2024 /PRNewswire/ -- Agora Data, a fintech company that provides technology, capital, and guidance with predictable loan performance and analytics for the subprime automotive industry, announces the appointment of Sharon Mancero as Managing Director.
  • Mancero joins Agora with an impeccable finance background and deep auto industry experience.
  • She will help introduce strategic initiatives that best leverage Agora's assets and auto financing talents to optimize portfolios and balances sheets for small to mid-sized institutions including banks, credit unions, and finance companies.
  • Mancero spent more than 30 years at Wells Fargo, 20 of which were in the Asset-Backed Finance group providing senior lending facilities to consumer finance companies in the U.S. and Canada.

ByHeart Appoints Amy Schulman as Chair of the Board of Directors, Further Solidifying its Position as a Leader in the Infant Nutrition Category

Retrieved on: 
Tuesday, March 5, 2024

NEW YORK, March 5, 2024 /PRNewswire/ --Today, ByHeart, the next-generation baby nutrition company, announced the appointment of Amy Schulman, managing partner at Polaris partners, as Chair of the Board. A stalwart supporter of ByHeart since its inception, Schulman's designation signifies a pivotal moment for the company as it experiences momentous growth and solidifies its position as an industry leader.

Key Points: 
  • "Amy's insights and passion for health innovation and social impact align with ByHeart's mission," said ByHeart Co-Founder and CEO Ron Belldegrun.
  • "We chose Amy as the Chair because of her extensive track record in life sciences and infant nutrition.
  • "I have been a staunch supporter of ByHeart from its early days, and I am honored to now chair their board," said Schulman.
  • ByHeart remains dedicated to advancing infant nutrition through science, innovation and a commitment to excellence.

Sabre Elects Gail Mandel to Become Chair of its Board of Directors

Retrieved on: 
Tuesday, March 5, 2024

SOUTHLAKE, Texas, March 5, 2024 /PRNewswire/ -- Sabre Corporation (NASDAQ: SABR), a leading technology provider to the global travel industry, today announced the election of Gail Mandel, former Wyndham Worldwide executive and existing Sabre Board member, to become non-executive Chair of the Board. Mandel has served on Sabre's Board since April 2020. Her appointment as Chair of the Board will be effective at the company's 2024 Annual Meeting, scheduled for April 24, 2024.

Key Points: 
  • SOUTHLAKE, Texas, March 5, 2024 /PRNewswire/ -- Sabre Corporation (NASDAQ: SABR), a leading technology provider to the global travel industry, today announced the election of Gail Mandel, former Wyndham Worldwide executive and existing Sabre Board member, to become non-executive Chair of the Board.
  • Her appointment as Chair of the Board will be effective at the company's 2024 Annual Meeting, scheduled for April 24, 2024.
  • "I am thrilled to serve as Chair of Sabre's Board at this important phase of the company's strategic transformation," said Mandel.
  • In addition to serving as Chair of the Board, Mandel will serve as Chair of the Corporate Governance and Nominating Committee and as a member of the Compensation Committee.

YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries

Retrieved on: 
Tuesday, March 5, 2024

GAITHERSBURG, Md., March 5, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced changes to its board of directors (the "Board") and key strategic appointments within its wholly-owned subsidiaries in China.

Key Points: 
  • GAITHERSBURG, Md., March 5, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced changes to its board of directors (the "Board") and key strategic appointments within its wholly-owned subsidiaries in China.
  • Each of Mr. Bo Tan and Mr. Shaojing Tong has resigned as a director of the Company for personal reasons, effective from February 29, 2024.
  • Their resignation did not result from any disagreement with the Company on any matter relating to the Company's operations, policies, or practice.
  • Following such new appointments, the senior officers of YS Biopharma includes (1) Dr. Hui Shao (David, President & CEO, Director), (2) Ms. Chunyuan Wu (Brenda, CFO), (3) Dr. Zenaida Mojares (Chief Medical Officer), (4) Mr.

Women Economic Forum to Honor Gaby Natale at Harvard Club

Retrieved on: 
Monday, March 4, 2024

NEW YORK, March 4, 2024 /PRNewswire/ -- The Women Economic Forum New York (WEFNY) announced its inaugural event on March 8, 2024, at the iconic Harvard Club in New York City, where triple Emmy-winning journalist, leadership speaker, and bestselling author Gaby Natale will be among the distinguished awardees.

Key Points: 
  • NEW YORK, March 4, 2024 /PRNewswire/ -- The Women Economic Forum New York (WEFNY) announced its inaugural event on March 8, 2024, at the iconic Harvard Club in New York City, where triple Emmy-winning journalist, leadership speaker, and bestselling author Gaby Natale will be among the distinguished awardees.
  • Upon being honored, Gaby Natale shared her thoughts: "Being recognized by the Women Economic Forum is not just a personal honor but a testament to the power of perseverance and vision.
  • "We are thrilled to launch Women Economic Forum New York and provide a space for women to come together, share their experiences, and empower one another," said Maria Fernanda Reyes, President of WEFNY.
  • Harbeen Arora Rai, Founder and Chairperson of the Women Economic Forum, will be among the distinguished guests at the event.

Dave O'Flanagan appointed Interim CEO of Sitecore

Retrieved on: 
Monday, March 4, 2024

SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Sitecore®, a global leader in end-to-end digital experience management software, today announced the appointment of Dave O'Flanagan as Interim CEO. Dave assumes the role having previously been Sitecore's Chief Product Officer. His commitment to technology and customer obsession will see the business further invest in Sitecore's Digital Experience Platform (DXP), advance its operational capabilities, and better enable its thriving partner ecosystem to enable customers to effectively differentiate, innovate, and grow. Dave is an experienced CEO, having led Boxever before it was acquired by Sitecore in 2021. Steve Tzikakis will remain as a special advisor to the Sitecore Board and support Dave through the transition.

Key Points: 
  • SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Sitecore® , a global leader in end-to-end digital experience management software, today announced the appointment of Dave O'Flanagan as Interim CEO.
  • Dave is an experienced CEO, having led Boxever before it was acquired by Sitecore in 2021.
  • Steve Tzikakis will remain as a special advisor to the Sitecore Board and support Dave through the transition.
  • Commenting on his appointment, Interim CEO of Sitecore, Dave O'Flanagan said: "I am honored to lead Sitecore into this next wave of growth.

Breathe Change: Lung Health Foundation Launches First of Three Landmark Policy Forums on Thursday, March 7

Retrieved on: 
Monday, March 4, 2024

LHF is the nation's leading non-profit organization dedicated to supporting and empowering individuals living with lung conditions across Canada.

Key Points: 
  • LHF is the nation's leading non-profit organization dedicated to supporting and empowering individuals living with lung conditions across Canada.
  • The session showcases the best-of-the-best in COPD and lung disease research, diagnosis and treatment modalities, and policy initiatives.
  • Dawn Bowdish, Executive Director, Firestone Institute for Respiratory Health and Dr. Maya de Zoysa, Respirologist, West Nipissing General Hospital.
  • For those navigating the labyrinth of lung disease, LHF offers an expansive array of disease-specific support programs and resources.

COALITION FOR HEALTH AI (CHAI) NAMES BOARD OF DIRECTORS AND CEO

Retrieved on: 
Monday, March 4, 2024

WASHINGTON, March 4, 2024 /PRNewswire/ -- Today CHAI, the Coalition for Health AI, announced Dr. Brian S. Anderson, a CHAI co-founder and chief digital health physician at MITRE, to be its first CEO. It also named members of CHAI's inaugural Board of Directors chaired by Dr. John Halamka, a CHAI co-founder and the president of Mayo Clinic Platform, as well as leaders of key advisory boards. CHAI includes representatives from over 1300 member organizations including hospital systems, tech, government agencies and advocacy groups. The board also opened general membership for individuals and organizations and formalized the process for joining and contributing to CHAI work groups.

Key Points: 
  • CHAI today also announced partnerships with the patient advocacy group, the National Health Council, and health standards organization, HL7.
  • To implement this commitment, CHAI established a governance structure extending beyond the Board of Directors to include a small number of strategically defined advisory boards.
  • I am excited to be a part of the Coalition for Health AI to help create a future where responsible AI practices are the cornerstone."
  • – Michael Pencina, board member
    "Decades of research have brought us to a transformative moment for AI and the applications in medicine are unbounded.

Jenny Machida Joins CD&R as Managing Director of Portfolio Talent

Retrieved on: 
Monday, March 4, 2024

NEW YORK, March 4, 2024 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced the appointment of Jenny Machida as Managing Director of Portfolio Talent, a newly created position to bring additional capability to support our investment teams' focus on talent across the investment life cycle.

Key Points: 
  • NEW YORK, March 4, 2024 /PRNewswire/ -- Clayton, Dubilier & Rice ("CD&R" or the "Firm") today announced the appointment of Jenny Machida as Managing Director of Portfolio Talent, a newly created position to bring additional capability to support our investment teams' focus on talent across the investment life cycle.
  • Ms. Machida has more than 25 years of experience in direct investing, management consulting and building businesses.
  • Prior to that, Ms. Machida was a Partner and Managing Director at private equity firm IMB Partners, where she played a lead role in talent due diligence, post-close strategic planning and in partnering with management teams to execute value creation initiatives.
  • Prior to IMB, Ms. Machida was co-founder, Chief Business Officer and Board Chair at a start-up medical diagnostic technology company called Sevident.